Ach-sitagliptin: May Exceed Established Acceptable Intake Limit For Nttp.
Recall Summary ACH-SITAGLIPTIN tablets are being recalled across Canada because they may contain higher levels of a substance called NTTP than the established safe limit. This is a Class I recall, meaning there is a serious potential health risk. The recall affects all ACH-SITAGLIPTIN products distributed in Canada.
- Product
- ACH-SITAGLIPTIN
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-08-13
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/0fc67db6-6d36-4d1f-8e7c-10c6fbd75a76